High income (World Bank) vs Hungary: Pneumococcal conjugate second or third-dose vaccines (PCVc)

High income (World Bank)
87.0%
in 2025
Hungary
99.0%
in 2025
High income (World Bank) rank
2nd
Hungary rank
1st

Pneumococcal conjugate second or third-dose vaccines (PCVc) over time

  • High income (World Bank)
  • Hungary
020406080100200820162025

How they compare

Hungary currently reports 99.0% against 87.0% in High income (World Bank), a difference of 12.0%.

That makes Hungary's figure about 1.1 times High income (World Bank)'s.

The two have swapped places 1 time across 18 shared years of data; in 2008 it was High income (World Bank) ahead.

High income (World Bank) ranks 2nd and Hungary ranks 1st of 11 groups.

Across the 3 decades both report, High income (World Bank) averaged higher in 1 and Hungary in 2.

Head to head by decade

Decade High income (World Bank) Hungary Difference Ahead
2000s 38.5% 0.0% 38.5% High income (World Bank)
2010s 73.3% 84.8% 11.5% Hungary
2020s 87.3% 99.0% 11.7% Hungary

Averages of every year both report within each decade.

Frequently asked questions

Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), High income (World Bank) or Hungary?
Hungary, at 99.0% against 87.0% in High income (World Bank) as of 2025.
What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between High income (World Bank) and Hungary?
12.0%, with Hungary ahead.
How many years of comparable data are there for High income (World Bank) and Hungary?
18 years are reported by both, from 2008 to 2025.
How do High income (World Bank) and Hungary rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
High income (World Bank) ranks 2nd and Hungary ranks 1st of 11 groups.
Where does this data come from?
World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

High income (World Bank) vs Hungary: Pneumococcal conjugate second or third-dose vaccines (PCVc). Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 01 September 2026, from https://health.statizoid.com/compare/pneumococcal-conjugate-second-or-third-dose-vaccines-pcvc-immunization-coverage-by-the/high-income-world-bank/hungary/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/pneumococcal-conjugate-second-or-third-dose-vaccines-pcvc-immunization-coverage-by-the/high-income-world-bank/hungary/">High income (World Bank) vs Hungary: Pneumococcal conjugate second or third-dose vaccines (PCVc)</a> — Statizoid

About this data

Indicator
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
207 places, 3,723 data points, 2008–2025
Last refreshed